The sympathetic system and hypertension

American Journal of Hypertension

Volumn 13, Issue 6 II SUPPL., 2000, Pages

  Esler, Murray ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Hypertension; I1 agents; Norepinephrine; Rilmenidine.; Sympathetic nervous system

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IMIDAZOLINE DERIVATIVE; NORADRENALIN; RILMENIDINE;

ADRENERGIC SYSTEM; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ESSENTIAL HYPERTENSION; GLUCOSE TRANSPORT; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; KIDNEY FUNCTION; MORTALITY; NEUROCHEMISTRY; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKELETAL MUSCLE; SYMPATHETIC NERVE; SYMPATHETIC TONE; VASCULARIZATION; VASOCONSTRICTION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; NOREPINEPHRINE; OXAZOLES; SYMPATHETIC NERVOUS SYSTEM;

EID: 0033912454     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. The CAST Investigators: Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
2. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD: Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995;26:1257-1263.
3. Packer M, Bristow MR, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-1355.
4. Esler M, Lambert G, Jennings G: Increased regional sympathetic nervous activity in human hypertension: causes and consequences. J Hypertens 1990;8(suppl 7): S53-S57.
5. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G: Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 1998;31:64-67.
6. Esler M, Jennings G, Lambert G, Meredith I, Home M, Eisenhofer G: Overflow of catecholamine neurotransmitters to the circulation: Source, fate and functions. Physiol Rev 1990;70:963-985.
7. Vallbo AB, Hagbarth K-E, Torebjork HE, Wallin BG: Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev 1979;59: 919-957.
8. Kingwell BA, Thompsom JM, Kaye DM, McPherson GA, Jennings GL, Esler MD: Heart rate spectral analysis, cardiac norepinephrine spillover and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994;90: 234-240.
9. Eckberg DL: Spectral balance: a critical appraisal. Circulation 1997;96:3224-3232.
10. Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M: Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension 1989;13:870-877.
11. Anderson EA, Sinkey CA, Lawton WJ, Mark AL: Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 1989;14:177-183.
12. Rostrup M, Mundal HH, Kjeldsen SE, Westheim A, Eide I: Awareness of high blood pressure increases arterial plasma catecholamines, platelet norepinephrine and adrenergic responses to mental stress. J Hypertens 1991;9:159-166.
13. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G: Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988;11:3-20.
14. Callister R, Suwarno NO, Seals DR: Sympathetic activity is influenced by task difficulty and stress perception during mental challenge in humans. J Physiol 1992;454: 373-387.
15. Kaye DM, Lefkovits J, Cox H, Lambert G, Jennings G, Turner A, Esler MD: Regional epinephrine kinetics in severe heart failure: evidence for extra-adrenal, non-neural release. Am J Physiol 1995;269:H182-H188.
16. Wallin BG, Kunimoto MM, Sellgren J: Possible genetic influence on the strength of human muscle nerve sympathetic activity at rest. Hypertension 1993;22:282-282.
17. Williams PD, Puddey IB, Beilin LJ, Vandongen R: Genetic influences on plasma catecholamines in human twins. J Clin Endocrinol Metab 1993;77:794-799.
18. Ferrier C, Cox H, Esler M: Elevated total body noradrenaline spillover in normotensive members of hypertensive families. Clin Sci 1993;84:225-230.
19. Esler M, Julius S, Zweifler A, Randall O, Harburg E, Gardiner H, DeQuattro V: Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med 1977;296:405-411.
20. Sherwood A, Hinderliter AL, Light KC: Physiological determinants of hyperreactivity to stress in borderline hypertension. Hypertension 1995;25:384-390.
21. Perini C, Muller FB, Rauchfleisch U, Battegay R, Buhler FR: Hyperadrenergic borderline hypertension is characterized by suppressed aggression. J Cardiovasc Pharmacol 1986;8 (suppl 5):S53-S56.
22. Poulter NR, Khaw KT, Hopwood BEC, Mugambi M, Peart WS, Rose G, Sever PS: The Kenyan Luo migration study: observations on the initiation of the rise in blood pressure. Br Med J 1990;300:967-972.
23. Timio M, Verdecchia P, Venanzi S, Gentili S, Ronconi M, Francucci B, Montanari M, Bichisao E: Age and blood pressure changes: a 20 year follow-up study in nuns in a secluded order. Hypertension 1988;12:457-461.
24. Koepke JP, Jones S, DiBona GF: Stress increases renal nerve activity and decreases sodium excretion in Dahl rats. Hypertension 1988;11:334-338.
25. Landsberg L: Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986;236: 1081-1090.
26. Jung RT, Shetty PS, Barrand M, Callingham BA, James WP: Role of catecholamines in hypotensive response to dieting. Br Med J 1979;1:12-13.
27. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M: Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997;96:3423-3429.
28. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP: Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995;25:893-897.
29. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP, Esler MD: Neural mechanisms in human obesity-related hypertension. J Hypertens 1999;17:1125-1133.
30. Jennings G, Nelson L, Nestel P, Esler M, Korner P, Burton D, Bazelmans J: The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. Circulation 1986;73:30-40.
31. Meredith IT, Frieberg P, Jennings GL, Dewar EM, Fazio VA, Lambert GW, Esler MD: Exercise training lowers resting renal but not cardiac sympathetic activity. Hypertension 1991;18:575-582.
32. Foote SL, Bloom FE, Aston-Jones G: Nucleus coeruleus: new evidence of anatomical and physiological specificity. Physiol Rev 1983;63:844-914.
33. Huangfu D, Koshiya N, Guyenet P: A5 noradrenergic unit activity and sympathetic nerve discharge in rats. Am J Physiol 1991;261:R393-R402.
34. Van Huysse JW, Bealer SL: Central nervous system norepinephrine release during hypotension and hyperosmolality in conscious rats. Am J Physiol 1991;260: R1071-R1076.
35. Ferrier C, Jennings GL, Eisenhofer G, Lambert G, Cox HS, Kalff V, Kelly M, Esler MD: Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens 1993;11:1217-1227.
36. Lambert GW, Vaz M, Cox HS, Turner AG, Kaye DM, Jennings GL, Esler MD: Human obesity is associated with a chronic elevation in brain 5-hydroxytryptamine turnover. Clin Sci (Colch) 1999;96:191-197.
37. Julius S, Gundbrandsson T, Jamerson K, Andersson O: The interconnection between sympathetics, microcirculation and insulin resistance in hypertension. Blood Press 1992;1:9-19.
38. Meredith LT, Broughton A, Jennings GL, Esler MD: Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991;325:618-624.
39. Mann DL, Kent RL, Parsons B, Cooper G 4th: Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992;85:790-804.
40. Ruzicka M, Leenen FHH: Relevance of intermittent increases in sympathetic activity for adverse outcome on short acting calcium antagonists, in: Laragh JH, Brenner BM (eds): Hypertension. Pathophysiology, Diagnosis and Management. Raven Press, New York 1995, pp 2815-2825.
41. Zweifler A, Esler M: Factors influencing the choice of antihypertensive agents. Postgrad Med 1976;60:18-85.